ASTROCYTOMA, GRADE III
Clinical trials for ASTROCYTOMA, GRADE III explained in plain language.
Never miss a new study
Get alerted when new ASTROCYTOMA, GRADE III trials appear
Sign up with your email to follow new studies for ASTROCYTOMA, GRADE III, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Electric field helmet tested for tough brain tumor – but only one patient tried it
Disease control CompletedThis study tested a wearable device called NOVOTTF-200A in people with recurrent Grade III astrocytoma, a type of brain cancer. The device delivers low-intensity electric fields to the brain to slow tumor growth. Only 1 participant was enrolled, and the main goal was to see if th…
Matched conditions: ASTROCYTOMA, GRADE III
Phase: NA • Sponsor: Daniela A. Bota • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New drug TG02 shows promise in early brain cancer trial
Disease control CompletedThis early-phase study tested a new drug called TG02 in 71 patients with aggressive brain cancers (anaplastic astrocytoma or glioblastoma). The goal was to find the safest dose when combined with either radiation or chemotherapy. The study included newly diagnosed elderly patient…
Matched conditions: ASTROCYTOMA, GRADE III
Phase: PHASE1 • Sponsor: European Organisation for Research and Treatment of Cancer - EORTC • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC